AIDS, ISSN 0269-9370, 11/2018, Volume 32, Issue 17, pp. 2439 - 2451
Interactions between the Fc segment of IgG and its receptors (FcγRs) found on cells such as natural killer cells, monocytes, macrophages and neutrophils can...
Development and progression | Care and treatment | Cell receptors | Genetic aspects | HIV infection | Health aspects
Development and progression | Care and treatment | Cell receptors | Genetic aspects | HIV infection | Health aspects
Journal Article
3.
Full Text
Adjuvant-dependent innate and adaptive immune signatures of risk of SIVmac251 acquisition
Nature Medicine, ISSN 1078-8956, 07/2016, Volume 22, Issue 7, pp. 762 - 770
A recombinant vaccine containing Aventis Pasteur's canarypox vector (ALVAC)-HIV and gp120 alum. decreased the risk of HIV acquisition in the RV144 vaccine...
ANTIBODIES | MEDICINE, RESEARCH & EXPERIMENTAL | ACTIVATION | PROTECTION | BIOCHEMISTRY & MOLECULAR BIOLOGY | HIV-1 VACCINE EFFICACY | CELL BIOLOGY | TRIAL | IMMUNOGENICITY | NK CELLS | SIMIAN IMMUNODEFICIENCY VIRUS | NITRIC-OXIDE | INFECTION | Alum Compounds - therapeutic use | Immunogenicity, Vaccine | Viral Vaccines - therapeutic use | Signal Transduction | Immunity, Mucosal | Interleukin-17 - immunology | Transcriptome | Macaca mulatta | Random Allocation | ras Proteins - immunology | Simian Acquired Immunodeficiency Syndrome - prevention & control | Immunity, Innate - immunology | SAIDS Vaccines - therapeutic use | Animals | Simian Acquired Immunodeficiency Syndrome - immunology | Immunoglobulin G - immunology | Lymphocytes | Viral Envelope Proteins - immunology | Membrane Glycoproteins - immunology | Adaptive Immunity - immunology | Adjuvants, Immunologic - therapeutic use | Simian Immunodeficiency Virus - immunology | Human immunodeficiency virus--HIV | Vaccines | Immune system
ANTIBODIES | MEDICINE, RESEARCH & EXPERIMENTAL | ACTIVATION | PROTECTION | BIOCHEMISTRY & MOLECULAR BIOLOGY | HIV-1 VACCINE EFFICACY | CELL BIOLOGY | TRIAL | IMMUNOGENICITY | NK CELLS | SIMIAN IMMUNODEFICIENCY VIRUS | NITRIC-OXIDE | INFECTION | Alum Compounds - therapeutic use | Immunogenicity, Vaccine | Viral Vaccines - therapeutic use | Signal Transduction | Immunity, Mucosal | Interleukin-17 - immunology | Transcriptome | Macaca mulatta | Random Allocation | ras Proteins - immunology | Simian Acquired Immunodeficiency Syndrome - prevention & control | Immunity, Innate - immunology | SAIDS Vaccines - therapeutic use | Animals | Simian Acquired Immunodeficiency Syndrome - immunology | Immunoglobulin G - immunology | Lymphocytes | Viral Envelope Proteins - immunology | Membrane Glycoproteins - immunology | Adaptive Immunity - immunology | Adjuvants, Immunologic - therapeutic use | Simian Immunodeficiency Virus - immunology | Human immunodeficiency virus--HIV | Vaccines | Immune system
Journal Article
Microbiology spectrum, 08/2014, Volume 2, Issue 4, p. AID
Antibodies can impact pathogens in the presence or in the absence of effector cells or effector molecules such as complement, and experiments can often sort...
Antibodies - therapeutic use | Animals | Humans | Communicable Diseases - immunology | Antibodies - immunology | Vaccines - immunology | Vaccines - administration & dosage
Antibodies - therapeutic use | Animals | Humans | Communicable Diseases - immunology | Antibodies - immunology | Vaccines - immunology | Vaccines - administration & dosage
Journal Article
Nature, ISSN 0028-0836, 2012, Volume 482, Issue 7383, pp. 89 - 93
Preclinical studies of human immunodeficiency virus type 1 (HIV-1) vaccine candidates have typically shown post-infection virological control, but protection...
ANTIBODIES | MEMORY | MULTIDISCIPLINARY SCIENCES | CELLULAR IMMUNE-RESPONSES | INFECTION | MACAQUES | LOW-DOSE CHALLENGE | VECTORS | BREADTH | Enzyme-Linked Immunosorbent Assay | AIDS Vaccines - immunology | Macaca mulatta - immunology | Male | Neutralization Tests | Antibodies, Neutralizing - immunology | HIV-1 - immunology | Animals | SAIDS Vaccines - immunology | Adenoviridae - genetics | Female | Adenoviridae - immunology | Viral Vaccines - immunology | Simian Immunodeficiency Virus - immunology | Prevention | Rhesus monkey | AIDS vaccines | Product development | Simian immunodeficiency virus | Diseases | Confidence intervals | Cytotoxicity | Immunization | Vaccines | Adenoviruses | Deoxyribonucleic acid--DNA
ANTIBODIES | MEMORY | MULTIDISCIPLINARY SCIENCES | CELLULAR IMMUNE-RESPONSES | INFECTION | MACAQUES | LOW-DOSE CHALLENGE | VECTORS | BREADTH | Enzyme-Linked Immunosorbent Assay | AIDS Vaccines - immunology | Macaca mulatta - immunology | Male | Neutralization Tests | Antibodies, Neutralizing - immunology | HIV-1 - immunology | Animals | SAIDS Vaccines - immunology | Adenoviridae - genetics | Female | Adenoviridae - immunology | Viral Vaccines - immunology | Simian Immunodeficiency Virus - immunology | Prevention | Rhesus monkey | AIDS vaccines | Product development | Simian immunodeficiency virus | Diseases | Confidence intervals | Cytotoxicity | Immunization | Vaccines | Adenoviruses | Deoxyribonucleic acid--DNA
Journal Article
Proceedings of the National Academy of Sciences of the United States of America, ISSN 0027-8424, 10/2015, Volume 112, Issue 41, p. 12675
 Broadly neutralizing anti-HIV-1 monoclonal antibodies, such as PG9, and its derivative RSH hold great promise in AIDS therapy and prevention. An important...
Proteins | Antigens | Monoclonal antibodies | Cytotoxicity | Cells | Binding sites
Proteins | Antigens | Monoclonal antibodies | Cytotoxicity | Cells | Binding sites
Journal Article
Journal of Immunology, ISSN 0022-1767, 12/2010, Volume 185, Issue 11, pp. 6876 - 6882
Journal Article
PLoS Pathogens, ISSN 1553-7366, 05/2009, Volume 5, Issue 5, pp. e1000433 - e1000433
Developing an immunogen that elicits broadly neutralizing antibodies (bNAbs) is an elusive but important goal of HIV vaccine research, especially after the...
PBL-SCID MICE | VAGINAL TRANSMISSION | DENDRITIC CELL | MACAQUE MONKEYS | HUMAN MONOCLONAL-ANTIBODY | MICROBIOLOGY | PASSIVE-IMMUNIZATION | SIMIAN IMMUNODEFICIENCY | HIV-1/SIV CHIMERIC VIRUS | VIROLOGY | DC-SIGN | IMMUNODEFICIENCY-VIRUS TYPE-1 | PARASITOLOGY | HIV Antibodies - blood | HIV Infections - prevention & control | Humans | AIDS Vaccines - immunology | Administration, Intravaginal | Neutralization Tests | HIV - immunology | Macaca mulatta | Viral Load | HIV Infections - immunology | Simian Acquired Immunodeficiency Syndrome - virology | HIV Antibodies - immunology | Vaginal Discharge - immunology | Leukocytes, Mononuclear - immunology | Female | Antibodies, Monoclonal - immunology | Simian Immunodeficiency Virus - immunology | Data Interpretation, Statistical | Simian Immunodeficiency Virus - pathogenicity | Enzyme-Linked Immunosorbent Assay | HIV Infections - virology | Cells, Cultured | RNA, Viral - analysis | HIV - pathogenicity | Animals | Simian Acquired Immunodeficiency Syndrome - immunology | Antibodies, Monoclonal - administration & dosage | Immunization, Passive | Genes, MHC Class I | AIDS vaccines | Research | HIV (Viruses) | T cells | Health aspects | Studies | AIDS | Acquired immune deficiency syndrome | Experiments
PBL-SCID MICE | VAGINAL TRANSMISSION | DENDRITIC CELL | MACAQUE MONKEYS | HUMAN MONOCLONAL-ANTIBODY | MICROBIOLOGY | PASSIVE-IMMUNIZATION | SIMIAN IMMUNODEFICIENCY | HIV-1/SIV CHIMERIC VIRUS | VIROLOGY | DC-SIGN | IMMUNODEFICIENCY-VIRUS TYPE-1 | PARASITOLOGY | HIV Antibodies - blood | HIV Infections - prevention & control | Humans | AIDS Vaccines - immunology | Administration, Intravaginal | Neutralization Tests | HIV - immunology | Macaca mulatta | Viral Load | HIV Infections - immunology | Simian Acquired Immunodeficiency Syndrome - virology | HIV Antibodies - immunology | Vaginal Discharge - immunology | Leukocytes, Mononuclear - immunology | Female | Antibodies, Monoclonal - immunology | Simian Immunodeficiency Virus - immunology | Data Interpretation, Statistical | Simian Immunodeficiency Virus - pathogenicity | Enzyme-Linked Immunosorbent Assay | HIV Infections - virology | Cells, Cultured | RNA, Viral - analysis | HIV - pathogenicity | Animals | Simian Acquired Immunodeficiency Syndrome - immunology | Antibodies, Monoclonal - administration & dosage | Immunization, Passive | Genes, MHC Class I | AIDS vaccines | Research | HIV (Viruses) | T cells | Health aspects | Studies | AIDS | Acquired immune deficiency syndrome | Experiments
Journal Article
PLoS Pathogens, ISSN 1553-7366, 08/2015, Volume 11, Issue 8, p. e1005042
HIV-1 mucosal transmission begins with virus or virus-infected cells moving through mucus across mucosal epithelium to infect CD4(+) T cells. Although broadly...
NEUTRALIZING ANTIBODIES | FAB FRAGMENT | CRYSTAL-STRUCTURE | EFFECTOR FUNCTION | MICROBIOLOGY | MEDIATING ANTIBODIES | VIRION CAPTURE | DEPENDENT CELLULAR CYTOTOXICITY | VIROLOGY | MEMBRANE PROXIMAL REGION | VACCINE EFFICACY | IMMUNODOMINANT DOMAIN | PARASITOLOGY | Surface Plasmon Resonance | Humans | Intestinal Mucosa - virology | Macaca mulatta | Reverse Transcriptase Polymerase Chain Reaction | CD4-Positive T-Lymphocytes - immunology | Simian Acquired Immunodeficiency Syndrome - prevention & control | HIV-1 - immunology | Animals | Viral Envelope Proteins - chemistry | Fluorescent Antibody Technique | Rectum | Antibodies, Viral - immunology | Protein Conformation | Viral Envelope Proteins - immunology | Antibodies, Monoclonal - immunology | Simian Immunodeficiency Virus - immunology | Monoclonal antibodies | Rhesus monkey | Host-virus relationships | Observations | HIV (Viruses) | Health aspects | HIV-1 | macaque | macrophages | rhesus monkeys | BASIC BIOLOGICAL SCIENCES | enzyme-linked immunoassays | antibodies | T cells | virions | Immunoglobulins | AIDS | Viruses | Infections | Vaccines | Crystallography | Immunology | HIV | Acquired immune deficiency syndrome | Human immunodeficiency virus | Mutation | Viral infections | Crystal structure
NEUTRALIZING ANTIBODIES | FAB FRAGMENT | CRYSTAL-STRUCTURE | EFFECTOR FUNCTION | MICROBIOLOGY | MEDIATING ANTIBODIES | VIRION CAPTURE | DEPENDENT CELLULAR CYTOTOXICITY | VIROLOGY | MEMBRANE PROXIMAL REGION | VACCINE EFFICACY | IMMUNODOMINANT DOMAIN | PARASITOLOGY | Surface Plasmon Resonance | Humans | Intestinal Mucosa - virology | Macaca mulatta | Reverse Transcriptase Polymerase Chain Reaction | CD4-Positive T-Lymphocytes - immunology | Simian Acquired Immunodeficiency Syndrome - prevention & control | HIV-1 - immunology | Animals | Viral Envelope Proteins - chemistry | Fluorescent Antibody Technique | Rectum | Antibodies, Viral - immunology | Protein Conformation | Viral Envelope Proteins - immunology | Antibodies, Monoclonal - immunology | Simian Immunodeficiency Virus - immunology | Monoclonal antibodies | Rhesus monkey | Host-virus relationships | Observations | HIV (Viruses) | Health aspects | HIV-1 | macaque | macrophages | rhesus monkeys | BASIC BIOLOGICAL SCIENCES | enzyme-linked immunoassays | antibodies | T cells | virions | Immunoglobulins | AIDS | Viruses | Infections | Vaccines | Crystallography | Immunology | HIV | Acquired immune deficiency syndrome | Human immunodeficiency virus | Mutation | Viral infections | Crystal structure
Journal Article
Journal of Virology, ISSN 0022-538X, 02/2010, Volume 84, Issue 3, pp. 1302 - 1313
Article Usage Stats Services JVI Citing Articles Google Scholar PubMed Related Content Social Bookmarking CiteULike Delicious Digg Facebook Google+ Mendeley...
LONG-TERM | HIV-1/SIV CHIMERIC VIRUS | T-CELL RESPONSES | EPITOPE | REPLICATION | VIROLOGY | CLASS-I ALLELES | PASSIVE TRANSFER | ENVELOPE GLYCOPROTEIN | INFECTION | RHESUS MACAQUES | Antibodies, Neutralizing - immunology | HIV-1 - immunology | Enzyme-Linked Immunosorbent Assay | HIV Envelope Protein gp41 - immunology | HIV-1 - isolation & purification | Humans | Immunity, Mucosal | HeLa Cells | Antibodies, Monoclonal - immunology | Viral Load | Simian Immunodeficiency Virus - immunology | Vaccines and Antiviral Agents
LONG-TERM | HIV-1/SIV CHIMERIC VIRUS | T-CELL RESPONSES | EPITOPE | REPLICATION | VIROLOGY | CLASS-I ALLELES | PASSIVE TRANSFER | ENVELOPE GLYCOPROTEIN | INFECTION | RHESUS MACAQUES | Antibodies, Neutralizing - immunology | HIV-1 - immunology | Enzyme-Linked Immunosorbent Assay | HIV Envelope Protein gp41 - immunology | HIV-1 - isolation & purification | Humans | Immunity, Mucosal | HeLa Cells | Antibodies, Monoclonal - immunology | Viral Load | Simian Immunodeficiency Virus - immunology | Vaccines and Antiviral Agents
Journal Article
11.
Full Text
Fc receptor but not complement binding is important in antibody protection against HIV
Nature, ISSN 0028-0836, 09/2007, Volume 449, Issue 7158, pp. 101 - 104
Most successful vaccines elicit neutralizing antibodies and this property is a high priority when developing an HIV vaccine(1,2). Indeed, passively...
CHALLENGE | MEDIATED PROTECTION | IN-VITRO | TRANSMISSION | REPLICATION | DENDRITIC CELLS | NEUTRALIZING ANTIBODY | MULTIDISCIPLINARY SCIENCES | IMMUNODEFICIENCY-VIRUS TYPE-1 | MONOCLONAL-ANTIBODY | RHESUS MACAQUES | HIV Infections - prevention & control | Immunity, Mucosal - immunology | Complement C1q - immunology | Humans | AIDS Vaccines - immunology | Macaca mulatta - immunology | Antibody-Dependent Cell Cytotoxicity - immunology | Complement System Proteins - immunology | Neutralization Tests | HIV - immunology | Viral Load | HIV Infections - immunology | Macaca mulatta - virology | Simian Acquired Immunodeficiency Syndrome - virology | HIV Antibodies - immunology | Time Factors | Female | Simian Immunodeficiency Virus - immunology | HIV Infections - blood | HIV Infections - virology | Simian Acquired Immunodeficiency Syndrome - blood | HIV Antibodies - chemistry | Complement C3 - immunology | Simian Acquired Immunodeficiency Syndrome - prevention & control | Animals | Receptors, Fc - immunology | HIV Antigens - immunology | Simian Acquired Immunodeficiency Syndrome - immunology | HIV Antibodies - genetics | Immunology | Vaccines | Human immunodeficiency virus | HIV | Monkeys & apes | Cells
CHALLENGE | MEDIATED PROTECTION | IN-VITRO | TRANSMISSION | REPLICATION | DENDRITIC CELLS | NEUTRALIZING ANTIBODY | MULTIDISCIPLINARY SCIENCES | IMMUNODEFICIENCY-VIRUS TYPE-1 | MONOCLONAL-ANTIBODY | RHESUS MACAQUES | HIV Infections - prevention & control | Immunity, Mucosal - immunology | Complement C1q - immunology | Humans | AIDS Vaccines - immunology | Macaca mulatta - immunology | Antibody-Dependent Cell Cytotoxicity - immunology | Complement System Proteins - immunology | Neutralization Tests | HIV - immunology | Viral Load | HIV Infections - immunology | Macaca mulatta - virology | Simian Acquired Immunodeficiency Syndrome - virology | HIV Antibodies - immunology | Time Factors | Female | Simian Immunodeficiency Virus - immunology | HIV Infections - blood | HIV Infections - virology | Simian Acquired Immunodeficiency Syndrome - blood | HIV Antibodies - chemistry | Complement C3 - immunology | Simian Acquired Immunodeficiency Syndrome - prevention & control | Animals | Receptors, Fc - immunology | HIV Antigens - immunology | Simian Acquired Immunodeficiency Syndrome - immunology | HIV Antibodies - genetics | Immunology | Vaccines | Human immunodeficiency virus | HIV | Monkeys & apes | Cells
Journal Article
Journal of Virology, ISSN 0022-538X, 12/2008, Volume 82, Issue 24, pp. 12449 - 12463
Article Usage Stats Services JVI Citing Articles Google Scholar PubMed Related Content Social Bookmarking CiteULike Delicious Digg Facebook Google+ Mendeley...
PROXIMAL EXTERNAL REGION | NEUTRALIZING ANTIBODIES | SEROCONVERSION | VIROLOGY | DENDRITIC CELLS | PRIMARY HIV-1 INFECTION | VACCINE DESIGN | ENVELOPE | CD4(+) T-CELLS | SUBTYPE-C INFECTION | MONOCLONAL-ANTIBODIES | HIV Infections - blood | Virion - immunology | env Gene Products, Human Immunodeficiency Virus - immunology | HIV Envelope Protein gp41 - immunology | Humans | Immunoglobulin M - immunology | HIV Infections - immunology | HIV-1 - immunology | Lymphocyte Activation - immunology | B-Lymphocytes - immunology | Immunoglobulin G - immunology | Models, Biological | Viremia - immunology | Kinetics | Viremia - transmission | Pathogenesis and Immunity
PROXIMAL EXTERNAL REGION | NEUTRALIZING ANTIBODIES | SEROCONVERSION | VIROLOGY | DENDRITIC CELLS | PRIMARY HIV-1 INFECTION | VACCINE DESIGN | ENVELOPE | CD4(+) T-CELLS | SUBTYPE-C INFECTION | MONOCLONAL-ANTIBODIES | HIV Infections - blood | Virion - immunology | env Gene Products, Human Immunodeficiency Virus - immunology | HIV Envelope Protein gp41 - immunology | Humans | Immunoglobulin M - immunology | HIV Infections - immunology | HIV-1 - immunology | Lymphocyte Activation - immunology | B-Lymphocytes - immunology | Immunoglobulin G - immunology | Models, Biological | Viremia - immunology | Kinetics | Viremia - transmission | Pathogenesis and Immunity
Journal Article
Nature, ISSN 0028-0836, 2009, Volume 457, Issue 7225, pp. 87 - 91
A recombinant adenovirus serotype 5 (rAd5) vector-based vaccine for HIV-1 has recently failed in a phase 2b efficacy study in humans. Consistent with these...
RESPONSES | IMMUNOGENICITY | ADENOVIRUS VECTORS | REPLICATION | MEMORY | HIV | MULTIDISCIPLINARY SCIENCES | INFECTION | MAMU-A-ASTERISK-01 | SIMIAN-IMMUNODEFICIENCY | IMMUNODEFICIENCY VIRUS SIVMAC239 | HIV Infections - prevention & control | Simian Acquired Immunodeficiency Syndrome - mortality | SAIDS Vaccines - administration & dosage | Humans | Vaccination | Macaca mulatta - immunology | Neutralization Tests | Viral Load | CD4-Positive T-Lymphocytes - immunology | Simian Acquired Immunodeficiency Syndrome - prevention & control | HIV Infections - immunology | Macaca mulatta - virology | Simian Acquired Immunodeficiency Syndrome - virology | Animals | SAIDS Vaccines - immunology | Simian Acquired Immunodeficiency Syndrome - immunology | Adenoviridae - genetics | Antibodies, Viral - immunology | Simian Immunodeficiency Virus - immunology | Prevention | Viral vaccines | Causes of | Dosage and administration | Research | Simian immunodeficiency virus | T cells | HIV infection | Health aspects | Immunization | Acquired immune deficiency syndrome--AIDS | Lymphocytes | Human immunodeficiency virus--HIV | Mortality | Monoclonal antibodies | Vaccines
RESPONSES | IMMUNOGENICITY | ADENOVIRUS VECTORS | REPLICATION | MEMORY | HIV | MULTIDISCIPLINARY SCIENCES | INFECTION | MAMU-A-ASTERISK-01 | SIMIAN-IMMUNODEFICIENCY | IMMUNODEFICIENCY VIRUS SIVMAC239 | HIV Infections - prevention & control | Simian Acquired Immunodeficiency Syndrome - mortality | SAIDS Vaccines - administration & dosage | Humans | Vaccination | Macaca mulatta - immunology | Neutralization Tests | Viral Load | CD4-Positive T-Lymphocytes - immunology | Simian Acquired Immunodeficiency Syndrome - prevention & control | HIV Infections - immunology | Macaca mulatta - virology | Simian Acquired Immunodeficiency Syndrome - virology | Animals | SAIDS Vaccines - immunology | Simian Acquired Immunodeficiency Syndrome - immunology | Adenoviridae - genetics | Antibodies, Viral - immunology | Simian Immunodeficiency Virus - immunology | Prevention | Viral vaccines | Causes of | Dosage and administration | Research | Simian immunodeficiency virus | T cells | HIV infection | Health aspects | Immunization | Acquired immune deficiency syndrome--AIDS | Lymphocytes | Human immunodeficiency virus--HIV | Mortality | Monoclonal antibodies | Vaccines
Journal Article